InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
11.71
-0.68 (-5.49%)
At close: Nov 17, 2026

InventisBio Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
71.0637.29168.79185.53--
Revenue Growth
-60.64%-77.91%-9.02%---
Cost of Revenue
4.915.023.92---
Gross Profit
66.1532.27164.87185.53--
Selling, General & Admin
38.5745.2652.560.8557.9647.71
Research & Development
431.18325.79384.35442.91461.49315.04
Other Operating Expenses
9.230.110.090.12-00.05
Operating Expenses
474.73383.76445.82513.18519.44362.8
Operating Income
-408.58-351.49-280.95-327.65-519.44-362.8
Interest Expense
-1.35-0.84-0.66-0.83-1.03-1.19
Interest & Investment Income
13.2925.8930.0240.4517.3812.76
Currency Exchange Gain (Loss)
-1.39-1.391.561.1819.99-11.33
Other Non Operating Income (Expenses)
1.26-0.11-0.11-0.27-0.2-0.21
EBT Excluding Unusual Items
-396.77-327.94-250.14-287.12-483.31-362.76
Gain (Loss) on Sale of Investments
2.752.491.3---
Gain (Loss) on Sale of Assets
-0.07-0.08--0
Other Unusual Items
14.898.828.573.15-0.184.85
Pretax Income
-379.2-316.63-240.2-283.98-483.49-357.91
Income Tax Expense
0.040.24----
Net Income
-379.24-316.87-240.2-283.98-483.49-357.91
Net Income to Common
-379.24-316.87-240.2-283.98-483.49-357.91
Net Income Growth
------
Shares Outstanding (Basic)
573576572575509459
Shares Outstanding (Diluted)
573576572575509459
Shares Change
-1.06%0.73%-0.53%12.97%10.91%-0.25%
EPS (Basic)
-0.66-0.55-0.42-0.49-0.95-0.78
EPS (Diluted)
-0.66-0.55-0.42-0.49-0.95-0.78
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-280.38-162.36-249.53-314.04-484.59-278.59
Free Cash Flow Per Share
-0.49-0.28-0.44-0.55-0.95-0.61
Gross Margin
93.10%86.54%97.67%100.00%--
Operating Margin
-575.00%-942.59%-166.45%-176.61%--
Profit Margin
-533.72%-849.74%-142.31%-153.06%--
Free Cash Flow Margin
-394.58%-435.41%-147.84%-169.27%--
EBITDA
-404.34-346.58-275.16-322.31-514.77-360.15
EBITDA Margin
---163.02%-173.73%--
D&A For EBITDA
4.244.95.795.344.682.64
EBIT
-408.58-351.49-280.95-327.65-519.44-362.8
EBIT Margin
---166.45%-176.61%--
Revenue as Reported
71.0637.29168.79185.53--